Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

NILOTINIB D-TARTRATE

NILOTINIB D-TARTRATE

Standard Dose
EQ 150MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NILOTINIB D-TARTRATE is listed in Drugs@FDA under application 218922 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NILOTINIB D-TARTRATE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor CIPLA Submission history Latest submission status date: 2025-07-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview NILOTINIB D-TARTRATE is listed in Drugs@FDA under application 218922 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NILOTINIB D-TARTRATE Form and strength CAPSULE;ORAL - EQ 150MG BASE Sponsor CIPLA Submission history Latest submission status date: 2025-07-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
NILOTINIB D-TARTRATE (NILOTINIB D-TARTRATE) | Drug Monograph | MedicHelpline